Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
1,739,800
-
Share change
-
-173,824
-
Total reported value
-
$24,925,337
-
Price per share
-
$14.33
-
Number of holders
-
27
-
Value change
-
-$1,914,703
-
Number of buys
-
15
-
Number of sells
-
18
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q2 2014
As of 30 Jun 2014,
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,739,800 shares.
The largest 10 holders included
Park West Asset Management LLC, Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, WALL STREET ASSOCIATES, Allianz Asset Management AG, FARALLON CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, NORTHERN TRUST CORP, SUNRISE PARTNERS LIMITED PARTNERSHIP /CT, and BANQUE PICTET & CIE SA.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.